Robert I. Scheinman

6.0k total citations · 2 hit papers
61 papers, 3.6k citations indexed

About

Robert I. Scheinman is a scholar working on Immunology, Molecular Biology and Cancer Research. According to data from OpenAlex, Robert I. Scheinman has authored 61 papers receiving a total of 3.6k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 19 papers in Molecular Biology and 17 papers in Cancer Research. Recurrent topics in Robert I. Scheinman's work include NF-κB Signaling Pathways (16 papers), Complement system in diseases (14 papers) and Cytokine Signaling Pathways and Interactions (9 papers). Robert I. Scheinman is often cited by papers focused on NF-κB Signaling Pathways (16 papers), Complement system in diseases (14 papers) and Cytokine Signaling Pathways and Interactions (9 papers). Robert I. Scheinman collaborates with scholars based in United States, United Kingdom and Japan. Robert I. Scheinman's co-authors include Albert S. Baldwin, Amer A. Beg, Christine M. Jewell, Antonio Gualberto, John A. Cidlowski, C A Rosen, Steven M. Ruben, A S Baldwin, Stephen Haskill and Dmitri Simberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Genes & Development.

In The Last Decade

Robert I. Scheinman

58 papers receiving 3.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Characterization of Mechanisms Involved in Transrepression of NF-κB by Activated Glucocorticoid Receptors

1995 680 citations Robert I. Scheinman, Antonio Gualberto et al. Molecular and Cellular Biology profile →
I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.

1992 655 citations Robert I. Scheinman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robert I. Scheinman United States	27	1.6k	1.3k	1.0k	583	525	61	3.6k
David S. Ucker United States	29	2.3k 1.4×	1.5k 1.1×	385 0.4×	649 1.1×	367 0.7×	61	5.1k
Pengcheng Zhu China	24	1.9k 1.2×	606 0.5×	982 0.9×	357 0.6×	270 0.5×	50	3.4k
Hongtao Liu China	32	2.0k 1.2×	712 0.5×	1.1k 1.1×	720 1.2×	217 0.4×	96	3.5k
Ping Wang China	37	2.2k 1.3×	1.2k 0.9×	1.0k 1.0×	806 1.4×	181 0.3×	206	4.5k
Ye Chen China	32	2.3k 1.4×	1.2k 0.9×	691 0.7×	963 1.7×	204 0.4×	136	4.6k
Ping Jin United States	36	2.0k 1.2×	1.1k 0.8×	670 0.6×	974 1.7×	397 0.8×	125	4.4k
Jian Song China	34	1.6k 1.0×	922 0.7×	464 0.4×	555 1.0×	250 0.5×	163	3.8k
Wei Qiu China	40	2.5k 1.5×	691 0.5×	1.1k 1.0×	860 1.5×	234 0.4×	112	4.3k
Hidemi Teramoto United States	26	3.9k 2.4×	781 0.6×	823 0.8×	1.0k 1.8×	426 0.8×	38	6.3k

Countries citing papers authored by Robert I. Scheinman

Since Specialization

Citations

This map shows the geographic impact of Robert I. Scheinman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert I. Scheinman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert I. Scheinman more than expected).

Fields of papers citing papers by Robert I. Scheinman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert I. Scheinman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert I. Scheinman. The network helps show where Robert I. Scheinman may publish in the future.

Co-authorship network of co-authors of Robert I. Scheinman

This figure shows the co-authorship network connecting the top 25 collaborators of Robert I. Scheinman. A scholar is included among the top collaborators of Robert I. Scheinman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robert I. Scheinman. Robert I. Scheinman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rosa, Francisco G. La, Larry W. Moreland, Luigi Nibali, et al.. (2025). Pathotype-Specific Expression of Granzyme-Perforin Pathway Genes and Their Association With Clinical Disease Activity in Early Rheumatoid Arthritis and in a Randomized Clinical Trial. Immune Network. 25(4). e25–e25.

Gaikwad, Hanmant, Nirmal K. Banda, V. Michael Holers, et al.. (2025). Enhanced immunocompatibility and hemocompatibility of nanomedicines across multiple species using complement pathway inhibitors. Science Advances. 11(28). eadw1731–eadw1731. 1 indexed citations

Li, Yue, Laura Saba, Robert I. Scheinman, et al.. (2024). Nanoparticle-Binding Immunoglobulins Predict Variable Complement Responses in Healthy and Diseased Cohorts. ACS Nano. 18(42). 28649–28658. 9 indexed citations

Holers, V. Michael, Rachel M. Frank, Michael J. Zuscik, et al.. (2024). Decay-Accelerating Factor Differentially Associates With Complement-Mediated Damage in Synovium After Meniscus Tear as Compared to Anterior Cruciate Ligament Injury. Immune Network. 24(2). e17–e17. 2 indexed citations

Li, Yue, Hanmant Gaikwad, Guankui Wang, et al.. (2023). Inhibition of acute complement responses towards bolus-injected nanoparticles using targeted short-circulating regulatory proteins. Nature Nanotechnology. 19(2). 246–254. 26 indexed citations

Gaikwad, Hanmant, Yue Li, Guankui Wang, et al.. (2022). Antibody-Dependent Complement Responses toward SARS-CoV-2 Receptor-Binding Domain Immobilized on “Pseudovirus-like” Nanoparticles. ACS Nano. 16(6). 8704–8715. 8 indexed citations

Vu, Vivian, Fangfang Chen, Guankui Wang, et al.. (2018). Immunoglobulin deposition on biomolecule corona determines complement opsonization efficiency of preclinical and clinical nanoparticles. Nature Nanotechnology. 14(3). 260–268. 243 indexed citations

Banda, Nirmal K., Robert I. Scheinman, Rasmus Pihl, et al.. (2018). Targeting of Liver Mannan-Binding Lectin–Associated Serine Protease-3 with RNA Interference Ameliorates Disease in a Mouse Model of Rheumatoid Arthritis. ImmunoHorizons. 2(8). 274–295. 15 indexed citations

Griffin, James I., Guankui Wang, Vivian Vu, et al.. (2017). Revealing Dynamics of Accumulation of Systemically Injected Liposomes in the Skin by Intravital Microscopy. ACS Nano. 11(11). 11584–11593. 29 indexed citations

10.

Mehta, Gaurav, Robert I. Scheinman, V. Michael Holers, & Nirmal K. Banda. (2015). A New Approach for the Treatment of Arthritis in Mice with a Novel Conjugate of an Anti-C5aR1 Antibody and C5 Small Interfering RNA. The Journal of Immunology. 194(11). 5446–5454. 45 indexed citations

11.

Scheinman, Robert I.. (2013). NF-κB and Rheumatoid Arthritis: Will Understanding Genetic Risk Lead to a Therapeutic Reward?. PubMed. 4(2). 93–110. 13 indexed citations

12.

Scheinman, Robert I., et al.. (2011). Functionalized STAT1 siRNA Nanoparticles Regress Rheumatoid Arthritis in A Mouse Model. Nanomedicine. 6(10). 1669–1682. 68 indexed citations

13.

Bai, Xiyuan, Kathryn Chmura, Alida R. Ovrutsky, et al.. (2010). Mycobacterium tuberculosis increases IP-10 and MIG protein despite inhibition of IP-10 and MIG transcription. Tuberculosis. 91(1). 26–35. 13 indexed citations

14.

Lang, Julie, et al.. (2006). Loss of a gimap/ian gene leads to activation of NF-κB through a MAPK-dependent pathway. Molecular Immunology. 44(4). 479–487. 12 indexed citations

15.

Spalding, Aaron C., Robert M. Jotte, Robert I. Scheinman, et al.. (2002). TRAIL and inhibitors of apoptosis are opposing determinants for NF-κB-dependent, genotoxin-induced apoptosis of cancer cells. Oncogene. 21(2). 260–271. 30 indexed citations

16.

Cota‐Gomez, Adela, Tak Yee Aw, Hiroshi Ichikawa, et al.. (2002). The Human Immunodeficiency Virus-1 Tat Protein Activates Human Umbilical Vein Endothelial Cell E-selectin Expression via an NF-κB-dependent Mechanism. Journal of Biological Chemistry. 277(17). 14390–14399. 59 indexed citations

17.

Moore, Jodene K., Robert I. Scheinman, & Donald Bellgrau. (2001). The Identification of a Novel T Cell Activation State Controlled by a Diabetogenic Gene. The Journal of Immunology. 166(1). 241–248. 8 indexed citations

18.

Tao, Yunxia, et al.. (1999). NF-κB functions as both a proapoptotic and antiapoptotic regulatory factor within a single cell type. Cell Death and Differentiation. 6(6). 570–582. 145 indexed citations

19.

Scheinman, Robert I., Antonio Gualberto, Christine M. Jewell, John A. Cidlowski, & Albert S. Baldwin. (1995). Characterization of Mechanisms Involved in Transrepression of NF-κB by Activated Glucocorticoid Receptors. Molecular and Cellular Biology. 15(2). 943–953. 680 indexed citations breakdown →

20.

Scheinman, Robert I., Vanessa J. Auld, Alan L. Goldin, et al.. (1989). Developmental Regulation of Sodium Channel Expression in the Rat Forebrain. Journal of Biological Chemistry. 264(18). 10660–10666. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact